Statistics at a Glance

At a Glance

Year New Cases - SEER 9 New Cases - SEER 13 Deaths - SEER 9 Incidence-Based Mortality Percent Surviving 5 Years - SEER 9
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 1.02 1.09 - - - - 75.52% 65.73%
1976 1.67 1.54 - - - - 64.68% 66.20%
1977 2.09 2.17 - - - - 61.24% 66.65%
1978 2.29 2.25 - - - - 61.35% 67.11%
1979 2.34 2.33 - - - - 68.77% 67.56%
1980 2.43 2.42 - - - - 69.44% 68.00%
1981 2.45 2.50 - - - - 67.40% 68.44%
1982 2.53 2.59 - - - - 71.06% 68.88%
1983 2.77 2.69 - - - - 65.88% 69.31%
1984 2.76 2.71 - - - - 71.44% 69.74%
1985 2.78 2.73 - - - - 72.98% 70.16%
1986 2.88 2.75 - - - - 68.89% 70.58%
1987 2.72 2.78 - - - - 69.85% 70.99%
1988 2.82 2.80 - - - - 72.36% 71.40%
1989 2.65 2.82 - - - - 68.75% 71.80%
1990 2.93 2.84 - - - - 69.61% 72.20%
1991 3.00 2.87 - - - - 72.67% 72.60%
1992 2.80 2.89 2.71 2.67 1.23 1.18 73.29% 72.99%
1993 2.79 2.91 2.66 2.70 1.10 1.20 74.75% 73.37%
1994 3.04 2.94 2.84 2.73 1.22 1.21 72.41% 73.75%
1995 2.83 2.96 2.74 2.77 1.27 1.23 73.21% 74.13%
1996 2.80 2.99 2.69 2.80 1.25 1.24 78.22% 75.80%
1997 3.09 3.01 2.84 2.83 1.21 1.26 78.10% 77.38%
1998 3.09 3.03 2.91 2.86 1.12 1.19 78.14% 78.87%
1999 3.01 3.06 2.79 2.89 1.09 1.13 78.60% 80.28%
2000 3.00 3.08 2.85 2.92 1.15 1.07 79.63% 81.60%
2001 2.96 3.11 2.83 2.96 0.95 1.01 84.31% 82.85%
2002 3.20 3.13 3.08 2.99 1.01 0.96 86.36% 84.02%
2003 3.36 3.16 3.22 3.02 0.98 0.91 88.24% 85.11%
2004 3.28 3.19 3.16 3.06 0.88 0.86 87.47% 86.14%
2005 3.21 3.21 3.07 3.09 0.80 0.82 85.19% 87.10%
2006 3.16 3.24 3.10 3.13 0.81 0.77 87.75% 88.00%
2007 3.22 3.26 3.01 3.16 0.73 0.73 90.11% 88.84%
2008 3.10 3.12 3.03 3.02 0.61 0.69 89.73% 89.63%
2009 2.96 2.98 2.85 2.88 0.75 0.66 90.18% 89.31%
2010 3.07 2.85 2.93 2.75 0.58 0.62 88.50% 88.98%
2011 2.68 2.73 2.60 2.63 0.62 0.59 - 88.64%
2012 2.54 2.61 2.42 2.51 0.58 0.56 - 88.29%
2013 2.59 2.66 2.53 2.56 0.51 0.53 - 87.93%
2014 2.79 2.72 2.71 2.60 0.48 0.50 - 87.56%
2015 2.75 2.78 2.59 2.65 0.45 0.48 - 87.18%

Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.


Percent Surviving
5 Years

87.8% 2008-2014

Number of New Cases and Deaths per 100,000: The number of new cases of follicular lymphoma was 2.6 per 100,000 men and women per year. The number of deaths was 0.5 per 100,000 men and women per year. These rates are age-adjusted and based on 2011-2015 cases and deaths.

Additional Information

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Follicular Lymphoma?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

87.8%

Percent Surviving
5 Years

87.8%

Based on data from SEER 18 2008-2014. Gray figures represent those who have died from follicular lymphoma. Green figures represent those who have survived 5 years or more.

5-Year Relative Survival by Sex, Age, and Race

Percent Surviving

Both Sexes 87.803985353
Males 87.301061419
Females 88.303784776
<55 93.959989978
55-64 90.698528207
65+ 81.750727999
White 87.639378031
Black 86.6962742
Other 90.752243938

SEER 18 2008-2014

Additional Information

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. The earlier follicular lymphoma is caught, the better chance a person has of surviving five years after being diagnosed. For follicular lymphoma, 15.3% are diagnosed at stage I. The 5-year survival for stage I follicular lymphoma is 89.9%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Follicular Lymphoma
Stage Percent of Cases 5-Year Relative Survival
Stage I
Only in Originating Layer of Cells
26% 94.6%
Stage II
Confined to Primary Site
15% 89.9%
Stage III
Spread to Regional Lymph Nodes
25% 87.4%
Stage IV
Cancer has Metastasized
27% 80.6%
Unknown
Unstaged
7% 87.9%

SEER 18 2008-2014, All Races, Both Sexes by Ann Arbor Stage

Additional Information

Number of New Cases

Who Gets This Cancer?

The number of new cases of follicular lymphoma was 2.6 per 100,000 men and women per year based on 2011-2015 cases.

Number of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Follicular Lymphoma
Males
All Races 2.8
White 3.1
Black 1.3
Asian/Pacific Islander 1.6
American Indian/Alaska Native 1.8
Hispanic 2.5
Non-Hispanic 2.9
Females
All Races 2.4
White 2.7
Black 1.1
Asian/Pacific Islander 1.3
American Indian/Alaska Native 1.2
Hispanic 2.4
Non-Hispanic 2.4

SEER 18 2011-2015, Age-Adjusted

Percent of New Cases by Age Group: Follicular Lymphoma
Age Range Percent of New Cases
<20 0.3%
20-34 1.6%
35-44 5.8%
45-54 15.9%
55-64 25.9%
65-74 27.6%
75-84 16.9%
>84 6.0%

Follicular lymphoma is most frequently diagnosed among people aged 65-74.

Median Age
At Diagnosis

63

SEER 18 2011-2015, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new follicular lymphoma cases have not changed significantly over the last 10 years. Death rates have been stable over 2006-2015. 5-year survival trends are shown below.

More About This Cancer

Non-Hodgkin Lymphoma

Figure: Lymph Nodes Above and Below the Diaphragm

Figure: This picture shows lymph nodes above and below the diaphragm. It also shows the lymph vessels, tonsils, thymus, and spleen.

Lymphoma is cancer that begins in cells of the lymph system. The lymph system is part of the immune system, which helps the body fight infection and disease. Because lymph tissue is found all through the body, lymphoma can begin almost anywhere.

The two main types of lymphoma are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). These can occur in both children and adults.

There are many different types of NHL that form from different types of white blood cells (B-cells, T-cells, NK cells). Most types of NHL form from B-cells. NHL may be indolent (slow-growing) or aggressive (fast-growing). The most common types of NHL in adults are diffuse large B-cell lymphoma, which is usually aggressive, and follicular lymphoma, which is usually indolent.

Additional Information

More Information

Here are some resources for learning more about non-Hodgkin lymphoma.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Follicular Lymphoma. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/follicular.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.